Clinical Trial Update: Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

This clinical trial entry reports the completion of a Phase 1 study of TAK-901 in adults with advanced solid tumors or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• TAK-901

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors, Lymphoma | Phase 1 | Status: COMPLETED